Linklaters has advised investment vehicles affiliated with Rhône, the global private equity firm, on the acquisition of a majority share of Invacare Holdings, based in the U.S., and Direct Healthcare Group (DHG), based in the UK, together with the associated financing.
The proposed acquisition brings together two companies with complementary capabilities and product lines in designing, manufacturing, and distributing medical devices that support an individual’s mobility, safety, and care.
Pending consultation with the relevant employee representative bodies and regulatory approvals, Rhône will hold a majority share in the combined business globally. DHG’s previous private equity backer, ARCHIMED, will retain a minority interest.
The investment will enable the combined global business to address both major and nuanced mobility challenges, whether moving from A to B or making critical small adjustments to repositioning, delivering real impact for individuals, caregivers, and healthcare systems.
Together, Invacare and DHG will operate with an expanded global footprint and a broader product and service offering across mobility, pressure care, and rehabilitation, with the aim of becoming one of Europe’s leading providers in the post-acute mobility care sector.